Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for REPAGLINIDE

Ingredient

REPAGLINIDE

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
JAMP REPAGLINIDE	0.5MG	TABLET	Resolved	2017-04-10	2020-04-29	6358
JAMP REPAGLINIDE	2MG	TABLET	Actual shortage	2025-11-04	2025-11-04	271015
JAMP REPAGLINIDE	2MG	TABLET	Resolved	2025-06-07	2025-09-22	259928
JAMP REPAGLINIDE	2.0MG	TABLET	Resolved	2017-04-10	2020-04-29	6364
JAMP REPAGLINIDE	1MG	TABLET	Actual shortage	2025-11-04	2025-11-04	271012
JAMP REPAGLINIDE	1MG	TABLET	Resolved	2025-06-07	2025-09-22	259925
JAMP REPAGLINIDE	1.0MG	TABLET	Resolved	2017-04-10	2020-04-29	6361
JAMP REPAGLINIDE	0.5MG	TABLET	Actual shortage	2025-11-04	2025-11-04	271009
REPAGLINIDE	2MG	TABLET	Resolved	2024-10-04	2024-10-21	239381
REPAGLINIDE	2MG	TABLET	Resolved	2018-11-08	2019-02-19	66478

Previous
1
2
3
4
5
Next

Showing 21 to 30 of 48

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
APO-REPAGLINIDE			Discontinued	2018-09-08	2018-09-15	60735
APO-REPAGLINIDE			Discontinued	2018-09-08	2018-09-15	60738
APO-REPAGLINIDE			Discontinued	2018-09-08	2018-09-15	60741
GLUCONORM 0.5MG	0.5MG	TABLET	Discontinued	2023-08-09	2024-03-04	201483
GLUCONORM 1.0MG	1.0MG	TABLET	Discontinued	2023-08-09	2024-03-04	201486
GLUCONORM 2.0MG	2.0MG	TABLET	Discontinued	2023-08-09	2024-09-05	201489

1

Showing 1 to 6 of 6